ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol.
Gabriel P A Costa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.